Kim, J.H. et al. 2017. Clinical outcomes of the sequential use of pazopanib followed by everolimus for the treatment of metastatic renal cell carcinoma: A multicentre study in Korea. Canadian Urological Association Journal. 12, 1 (Nov. 2017), E15–20. DOI:https://doi.org/10.5489/cuaj.4644.